Cosgrove, N. D., A. M. Al-Osaimi, H. K. Sanoff, M. M. Morris, P. W. Read, D. G. Cox, J. A. Mann, et al. “Photodynamic therapy provides local control of cholangiocarcinoma in patients awaiting liver transplantation.” Am J Transplant 14, no. 2 (February 2014): 466–71. https://doi.org/10.1111/ajt.12597.
Goyal, Lipika, Jeffrey G. Supko, Jordan Berlin, Lawrence S. Blaszkowsky, Amanda Carpenter, Douglas M. Heuman, Sarah L. Hilderbrand, et al. “Phase 1 study of N(1),N(11)‑diethylnorspermine (DENSPM) in patients with advanced hepatocellular carcinoma.” Cancer Chemotherapy and Pharmacology 72, no. 6 (December 2013): 1305–14. https://doi.org/10.1007/s00280-013-2293-8.
Bleibel, W., C. L. Berg, and A. Y. Wang. “Chronic abdominal pain in a liver transplant recipient.” Am J Transplant 13, no. 5 (May 2013): 1364–66. https://doi.org/10.1111/ajt.12156.
Enfield, Kyle B., Umid Sharapov, Keri K. Hall, John Leiner, Carl L. Berg, Guo-liang Xia, Nicola D. Thompson, Lilia Ganova-Raeva, and Costi D. Sifri. “Transmission of hepatitis B virus from an orthopedic surgeon with a high viral load.” Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 56, no. 2 (January 2013): 218–24. https://doi.org/10.1093/cid/cis869.
Kulik, L. M., R. A. Fisher, D. R. Rodrigo, R. S. Brown, C. E. Freise, A. Shaked, J. E. Everhart, et al. “Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma: results of the A2ALL cohort.” Am J Transplant 12, no. 11 (November 2012): 2997–3007. https://doi.org/10.1111/j.1600-6143.2012.04272.x.
Volk, Michael L., and Carl L. Berg. “Declined organ offers in liver transplantation: careful timing or missed opportunity?” Gastroenterology 143, no. 5 (November 2012): 1141–43. https://doi.org/10.1053/j.gastro.2012.09.022.
Terrault, Norah A., Michelle E. Roland, Thomas Schiano, Lorna Dove, Michael T. Wong, Fred Poordad, Margaret V. Ragni, et al. “Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection.” Liver Transpl 18, no. 6 (June 2012): 716–26. https://doi.org/10.1002/lt.23411.
Northup, Patrick G., and Carl L. Berg. “Hepatocellular carcinoma and model for end-stage liver disease exceptions: the more we understand, the more challenging the allocation gets.” Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 18, no. 4 (April 2012): 381–83. https://doi.org/10.1002/lt.23409.
Cupino, A. C., C. D. Hair, J. F. Angle, S. H. Caldwell, T. A. Rich, C. L. Berg, P. G. Northup, A. M. S. Al-Osaimi, and C. K. Argo. “Does external beam radiation therapy improve survival following transarterial chemoembolization for unresectable hepatocellular carcinoma?” Gastrointestinal Cancer Research 5, no. 1 (January 1, 2012): 13–17.
Argo, C. K., G. J. Stukenborg, T. M. Schmitt, S. C. Kumer, C. L. Berg, and P. G. Northup. “Regional variability in symptom-based MELD exceptions: a response to organ shortage?” Am J Transplant 11, no. 11 (November 2011): 2353–61. https://doi.org/10.1111/j.1600-6143.2011.03738.x.